InvestorsObserver
×
News Home

Is Seres Therapeutics Inc (MCRB) Stock a Great Value?

Tuesday, September 29, 2020 01:48 PM | InvestorsObserver Analysts

Mentioned in this article

Is Seres Therapeutics Inc (MCRB) Stock a Great Value?

Seres Therapeutics Inc (MCRB) stock has gained 613.47% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MCRB stock a score of 77 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 100. MCRB's rank also includes a short-term technical score of 94. The fundamental score for MCRB is 37. In addition to the average rating from Wall Street analysts, MCRB stock has a mean target price of 34.75. This means analysts expect the stock to add 21.46% over the next 12 months.

Overall Score - 77
MCRB has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on MCRB!

What's Happening with MCRB Stock Today

Seres Therapeutics Inc (MCRB) stock is up 6.79% while the S&P 500 is lower by -0.41% as of 1:45 PM on Tuesday, Sep 29. MCRB has gained $1.82 from the previous closing price of $26.79 on volume of 784,266 shares. Over the past year the S&P 500 is up 12.13% while MCRB has gained 613.47%. MCRB lost -$1.07 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Seres Therapeutics Inc (MCRB) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App